Once-daily fluticasone propionate in stable asthma: study on airway inflammation

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
Albert M LiTai F Fok

Abstract

Children with stable asthma receiving twice-daily fluticasone propionate (FP) were studied. Spirometry, exhaled nitric oxide (eNO) and sputum eosinophils were measured at baseline and 8 weeks after FP was changed to once-daily use while keeping the same total dosage. Visual analogue scores on asthma severity, symptoms, and dosing regimen preference were obtained. Twenty-nine children of mean age 10.6 years (SD 2.5) were recruited. There was significant improvement in eNO (47.1 ppb [30.3] vs. 39.9 ppb [27.1], p = 0.037), and sputum eosinophils (5.7% [6.5] vs. 2.5% [3.9], p = 0.024] after 8 weeks. All subjects preferred the once-daily dosing regimen. Once-daily FP is effective in controlling airway inflammation. This frequency of medication use is also the preferred regimen.

References

Jun 1, 1992·Thorax·D M Geddes
Nov 1, 1990·Respiratory Medicine·S M Harding
May 1, 1995·Chest·D P Tashkin
Apr 1, 1994·Respiratory Medicine·A H JonesP D Richardson
Dec 1, 1996·The Journal of Allergy and Clinical Immunology·H MilgromC Rand
Jul 1, 1997·The European Respiratory Journal·N EsmailpourP Rohdewald
Sep 26, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·B BenderC Rand
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·E CrimiV Brusasco
May 1, 1998·The Journal of Allergy and Clinical Immunology·H DerendorfJ Barth
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·A J ApterR L ZuWallack
Jul 21, 2000·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·L P BouletR Robson
Dec 2, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C F LaForceK W House
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·J V FahyUNKNOWN NHLBI Asthma Clinical Research Network
Oct 27, 2001·British Journal of Clinical Pharmacology·B J Lipworth
Oct 24, 2002·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·William E BergerKathleen Rickard

❮ Previous
Next ❯

Citations

Dec 5, 2006·The Journal of Allergy and Clinical Immunology·Christine A SorknessUNKNOWN Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.